• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[益智制剂:成就与新问题]

[Nootropic preparations, the achievements and new problems].

作者信息

Voronina T A, Seredenin S B

机构信息

Laboratory of Psychopharmacology, Russian Academy of Medical Sciences, Moscow, Russia.

出版信息

Eksp Klin Farmakol. 1998 Jul-Aug;61(4):3-9.

PMID:9783097
Abstract

Recent studies in the field of molecular neurochemistry have demonstrated new mechanisms of regulation of the processes of training and memory, and on the basis of this new nootropic agents have been created. This work analyses in detail the most promising directions of research into the development of new nootropics acting on the deficiencies of synaptic transmission (cholinergic, glutamatergic. GAMA-ergic), free-radical affections, and peptidergic processes. Chemical heterogeneity, the wide variety of effects, and the difference in the mechanisms of action of the family of nootropics creates essential difficulties in the definition, classification, and determination of the mechanism of the nootropic effect proper, which is a frequent cause of the disagreement between the experimental and clinical data. Discussion of these problems is the subject of the present article.

摘要

分子神经化学领域的最新研究揭示了训练和记忆过程调节的新机制,并在此基础上研发出了新型益智药。本文详细分析了针对突触传递缺陷(胆碱能、谷氨酸能、γ-氨基丁酸能)、自由基影响和肽能过程开发新型益智药最具前景的研究方向。益智药家族的化学异质性、广泛的作用效果以及作用机制的差异,给正确定义、分类和确定益智作用机制带来了极大困难,这也是实验数据与临床数据不一致的常见原因。本文将对这些问题展开讨论。

相似文献

1
[Nootropic preparations, the achievements and new problems].[益智制剂:成就与新问题]
Eksp Klin Farmakol. 1998 Jul-Aug;61(4):3-9.
2
[The role of synaptic transmission in memory and neurodegeneration processes and effects of neurotropic preparations].[突触传递在记忆和神经退行性变过程中的作用以及神经营养制剂的影响]
Eksp Klin Farmakol. 2003 Mar-Apr;66(2):10-4.
3
[Nootropes (cognition enhancers) and neuroprotectors].[益智药(认知增强剂)和神经保护剂]
Eksp Klin Farmakol. 2007 Jul-Aug;70(4):44-58.
4
[Modern problems of the pharmacology of nootropic agents: the status and outlook].
Farmakol Toksikol. 1991 Mar-Apr;54(2):6-11.
5
[Memory disorders due to extreme exposures and their pharmacological correction].[极端暴露所致记忆障碍及其药物纠正]
Usp Fiziol Nauk. 1997 Jan-Mar;28(1):97-116.
6
PASS-predicted design, synthesis and biological evaluation of cyclic nitrones as nootropics.基于PASS预测的环状硝酮作为益智药的设计、合成及生物学评价
Bioorg Med Chem Lett. 2007 Sep 15;17(18):5251-5. doi: 10.1016/j.bmcl.2007.06.071. Epub 2007 Jun 30.
7
In search of the mechanism of action of the nootropics: new insights and potential clinical implications.探寻益智药的作用机制:新见解与潜在临床意义
Life Sci. 1994;55(25-26):2171-8. doi: 10.1016/0024-3205(94)00398-x.
8
[New trends in the search for nootropic preparations].[寻找益智制剂的新趋势]
Vestn Ross Akad Med Nauk. 1998(11):16-21.
9
Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice.促智药奈非西坦对小鼠的非阿片类及神经病变特异性镇痛作用。
J Pharmacol Exp Ther. 2002 Oct;303(1):226-31. doi: 10.1124/jpet.102.037952.
10
Glucose enhancement of human memory: a comprehensive research review of the glucose memory facilitation effect.葡萄糖增强人类记忆:葡萄糖记忆促进效应的综合研究综述。
Neurosci Biobehav Rev. 2011 Jan;35(3):770-83. doi: 10.1016/j.neubiorev.2010.09.008. Epub 2010 Sep 29.

引用本文的文献

1
Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.诺肽普与吡拉西坦治疗血管性和创伤性器质性脑疾病所致轻度认知障碍患者的对比研究。
Neurosci Behav Physiol. 2009 Mar;39(3):311-21. doi: 10.1007/s11055-009-9128-4.
2
Effects of combined treatment with heavy metals and piracetam on learning and memory in rats.重金属与吡拉西坦联合治疗对大鼠学习记忆的影响。
Dokl Biol Sci. 2008 Sep-Oct;422:301-4. doi: 10.1134/s0012496608050062.